These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 14692547)
1. What is your diagnosis? Ocular lymphoma. Cave T; Billson M J Small Anim Pract; 2003 Dec; 44(12):523, 553-4. PubMed ID: 14692547 [No Abstract] [Full Text] [Related]
2. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007). Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma. Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577 [TBL] [Abstract][Full Text] [Related]
4. Treatment of canine lymphoma with COPLA/LVP. Boyce KL; Kitchell BE J Am Anim Hosp Assoc; 2000; 36(5):395-403. PubMed ID: 10997514 [TBL] [Abstract][Full Text] [Related]
5. Lymphoma: which chemotherapy protocol and why? Chun R Top Companion Anim Med; 2009 Aug; 24(3):157-62. PubMed ID: 19732735 [TBL] [Abstract][Full Text] [Related]
6. Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs. Greenberg CB; Boria PA; Borgatti-Jeffreys A; Raskin RE; Lucroy MD J Am Anim Hosp Assoc; 2007; 43(1):27-32. PubMed ID: 17209082 [TBL] [Abstract][Full Text] [Related]
7. In vitro immune monitoring of antibody response in dogs given chemoimmunotherapy for lymphoma. Jeglum KA; Winters WD; Young KM Am J Vet Res; 1989 Apr; 50(4):488-92. PubMed ID: 2712415 [TBL] [Abstract][Full Text] [Related]
8. High-mobility group B1 proteins in canine lymphoma: prognostic value of initial and sequential serum levels in treatment outcome following combination chemotherapy. Meyer A; Eberle N; Bullerdiek J; Nolte I; Simon D Vet Comp Oncol; 2010 Jun; 8(2):127-37. PubMed ID: 20579326 [TBL] [Abstract][Full Text] [Related]
9. Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma. Ferrari A; Luppi M; Lazzerini A; Potenza L; Cavallini GM; Torelli G Lancet Oncol; 2006 Mar; 7(3):274. PubMed ID: 16510339 [No Abstract] [Full Text] [Related]
10. Natural killer cell activity in untreated and treated dogs with lymphoma. Raskin RE; Tvedten HW; Bull RW; Crow SE; Dunstan RW; Krehbiel JD Am J Vet Res; 1989 Apr; 50(4):483-7. PubMed ID: 2712414 [TBL] [Abstract][Full Text] [Related]
11. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs. Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510 [TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with vincristine, cyclophosphamide, and prednisone producing long-term remission of a transplanted canine lymphoma. Cohen H; Schmidt CE; Lucas SR; Palmer JL Am J Vet Res; 1975 Oct; 36(10):1483-7. PubMed ID: 1238040 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs. Rassnick KM; Moore AS; Collister KE; Northrup NC; Kristal O; Chretin JD; Bailey DB J Vet Intern Med; 2009; 23(2):317-22. PubMed ID: 19192147 [TBL] [Abstract][Full Text] [Related]
20. Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs. Gray KN; Raulston GL; Gleiser CA; Jardine JH J Am Vet Med Assoc; 1984 Apr; 184(7):814-7. PubMed ID: 6725115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]